| Clinical Outcome | Pre-EHM 2016 N=45 | Post-EHM 2020 N=27 | Change Post vs Pre | Estimated cost per case | Cost Avoidance |
|---|---|---|---|---|---|
| Medical necrotizing enterocolitis, n | 2 | 1 | 1 | $74,004 | $74,004 |
| Late-onset sepsis, n | 4 | 5 | -1 | $10,055 | -$10,055 |
| Bronchopulmonary dysplasia, n | 9 | 5 | 4 | $31,565 | $126,260 |
| Severe retinopathy of prematurity, n | 2 | 3 | -1 | $35,749 | - $35,749 |
| Total parenteral nutrition, days* | 34 | 27 | 7 | $1,436 | $271,404 |
| Length-of-stay, days* | 87.2 | 74.3 | 12.9 | $3,500 | $1,219,050 |
| Cost Avoidance | $1,644,914 | ||||
| Product Acquisition 2020 | - $313,784 | ||||
| Net Financial Impact | $1,331,130 | ||||
*mean